Idrabiotaparinux sodium

DRUG3 trials

Sponsors

Sanofi

Conditions

Atrial FibrillationDeep Venous ThrombosisEmbolismThrombosis

Phase 3

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

CompletedNCT00311090

SanofiDeep Venous Thrombosis

Start: 2006-04-30End: 2008-01-31Updated: 2016-03-21

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

CompletedNCT00345618

SanofiEmbolism, Thrombosis

Start: 2006-06-30End: 2010-10-31Updated: 2016-03-21

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

TerminatedNCT00580216

SanofiAtrial Fibrillation

Start: 2007-12-31End: 2010-10-31Updated: 2016-03-21

Related Papers

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.

2011-11-2842 citations